Astellas earmarks $354.2M for Irish build; Samsung Biologics get into ADCs; Rentschler gets UK facility approved
Welcome to our new look for manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls, and more.
This week, we take …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
